seres therapeutics stock price target
Seres Therapeutics has a 1-year low of 250 and a 1-year high of 1169. MCRB was reported by Piper Sandler on September 7 2022The analyst firm set a price target for 900 expecting MCRB to rise to.
Mcrb Stock Price And Chart Nasdaq Mcrb Tradingview
CAMBRIDGE - Seres Therapeutics Inc.
. MCRB a leading microbiome therapeutics company today announced the publication of Phase 3 clinical data in the Journal. Seres Therapeutics Inc MCRB Stock Price Target Coming Catalysts 2021MCRB is largely held by institutional investors. Seres Therapeutics Inc stock price target predictions for 2022 2023 2024 2025 2026 2027 2028 2029 and 2030 using artificial intelligence.
That Seres Therapeuticss share price could reach 900 by Sep 7 2023. Get a free in-depth analysis of Seres Therapeutics MCRB stock. The Wall Street analyst predicted.
Their MCRB share price forecasts range from 900 to 2500. Based on short-term price targets offered by five analysts the average price target for Seres Therapeutics comes to 1420. Shares of MCRB opened at 653 on Friday.
3 equities research analysts have issued 12-month target prices for Seres Therapeutics stock. Evolution of the average Target Price on SERES THERAPEUTICS INC. Get a real-time Seres Therapeutics Inc.
The forecasts range from a low of 900 to a high of. Seres Therapeutics Inc. AU Stock Market Overview.
Target Price consensus revisions. MCRB IEX Real-Time Price USD 700. The average price target is 1533 with a high.
MCRB Stock Price Prediction. Stock quotes are provided by Factset Morningstar and SP Capital IQ. The average Seres Therapeutics stock price prediction forecasts a potential upside of.
According to 14 stock analysts the average 12-month stock price. Seres Therapeutics Price Performance. Analyst Recommendations on SERES THERAPEUTICS INC.
Seres Therapeutics stock forecast analyst price target predictions based on 4 analysts offering 12-months price targets for MCRB in the last 3 months. The 9 analysts offering price forecasts for Seres Therapeutics have a median target of 2078 with a high estimate of 4600 and a low estimate of 700. Seres Therapeutics stock forecast analyst price target predictions based on 4 analysts offering 12-months price targets for MCRB in the last 3 months.
Based on 4 Wall Street analysts offering 12 month price targets for Seres Therapeutics in the last 3 months. Find Seres Therapeutics Smart Score expert sentiment charts stats. Seres Therapeutics Target Price Projection Seres Therapeutics current and average target prices are 693 and 2283 respectively.
The latest price target for. Get a real-time Seres Therapeutics Inc. The stock has a.
Last 18 months Recommendations Chart SERES THERAPEUTICS INC. How much will Seres. The 7 analysts offering 12-month price forecasts for Seres Therapeutics Inc have a median target of 1200 with a high estimate of 2500 and a low estimate of 400.
The median estimate represents a. To be precise 8120 of Shares Outs. The current price of Seres Therapeutics is the price at.
Seres Therapeutics Stock Forecast Invest in MCRB NASDAQMCRB. MCRB stock price quote with breaking news financials statistics charts and more.
Seres Therapeutics Inc Research Ratings Mcrb Barron S
Seres Therapeutics Reiterating Buy Rating With Price Target Increased To 15 Nasdaq Mcrb Seeking Alpha
Is Seres Therapeutics Still A Buy After Disappointing Ser 287 Topline Results
Seres Therapeutics Inc Mcrb Stock Price Quote News Stock Analysis
Why Seres Therapeutics Stock Skyrocketed 350 Today The Motley Fool
Mcrb Seres Therapeutics Inc Dividend History Dividend Channel
Seres Therapeutics Inc Mcrb Stock Price Quote News Stock Analysis
Mcrb Seres Therapeutics Inc Stock Overview U S Nasdaq Barron S
Seres Therapeutics Biotech Reviews
Is Seres Therapeutics Inc Mcrb Stock At The Top Of The Biotechnology Industry
Why The Fitbit Nyse Fit Stock Price Is Up Today
Is Seres Therapeutics Nasdaq Mcrb A Risky Investment Nasdaq
Mcrb Seres Therapeutics Inc Stock Overview U S Nasdaq Barron S
Best Biotech Stocks Which Companies Have Growth Potential
Mcrb Stock Price Forecast Should You Buy Mcrb
Form 10 K Seres Therapeutics Inc For Dec 31
Seres Therapeutics Mcrb Historical Forecast Data Trefis Trefis